|

Apatinib Mesylate Tablets Clinical Trials

2 actively recruiting trials

▲ +1 trial since August 2026

Pipeline

Phase 2: 1

Top Sponsors

  • Yunpeng Liu1
  • The First Affiliated Hospital of Bengbu Medical University1

Indications

  • Cancer2
  • Apatinib1
  • Biomarker1
  • Gastric Cancer1
  • Small Cell Lung Cancer1

Other2 trials

Adebrelimab Plus Apatinib for Maintenance Therapy of Extensive Stage Small Cell Lung Cancer
N/A
Apatinib as the First-Line Therapy in Elderly Locally Advanced or Metastatic Gastric Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.